CUTANEOUS INVOLVEMENT IN MULTIPLE MYELOMA IN THE ERA OF PROTEASOME INHIBITORS: HAS THE DISMAL PROGNOSIS CHANGED? FZ Piazera, AR Costa, GR Lima, JVO Maldonado, HM Bitencourte, RS Vasconcelos

Anaplastic morphology in IgD multiple myeloma Verónica Roldán Galiacho, Maite Moreno Gamiz, Idoya Ancin Arteaga, Marta Alonso Varela, Elena Amutio Díez, Juan Carlos García-Ruiz

THE EVOLVING ROLE OF PROTEASOME INHIBITORS IN CANCER TREATMENT Alpay Yeşilaltay